SlideShare una empresa de Scribd logo
1 de 26
Melissa Haendel@ontowonka
@monarchinit
Phenotype Ontologies (and a bit of G2P) task team
Genes Environment Phenotypes
Determinants of Health are Diverse
 Physical environment
 Chemical exposures
 Treatments
 Smoking, alcohol
 Education
 Health services
 Income
 Social status
 Stress
 Employment
 Working conditions
 Microbiome
 Pathogens
 Clinical observations
 Laboratory tests
 Patient reported outcomes
 Child development
 Biometrics
 Behaviors
 Sleep
 Exercise
 Screen time
 Diet
 Genomic endowment
 Epigenetics
 Gene expression
 Gene regulation
Ontologies can help make (some of) this
computable
Genes Environment Phenotypes+ =
But its not just the types of things
…the relationships and their evidence must also be
captured
G-P or D (disease)
• causes
• contributes to
• is risk factor for
• protects against
• correlates with
• is marker for
• modulates
• involved in
• increases susceptibility to
G-G (kind of)
• regulates
• negatively regulates (inhibits)
• positively regulates (activates)
• directly regulates
• interacts with
• co-localizes with
• co-expressed with
P/D - P/D
• part of
• results in
• co-occurs with
• correlates with
• hallmark of (P->D)
E-P
• contributes to (E->P)
• influences (E->P)
• exacerbates (E->P)
• manifest in (P->E)
G-E (kind of)
• expressed in
• expressed during
• contains
• inactivated by
The Human Phenotype Ontology
 11,813
phenotype
terms
 127,125 rare
disease -
phenotype
annotations
 136,268
common
disease -
phenotype
annotations
bit.ly/hpo-paper
Peter Robinson, Sebastian Koehler, Chris Mungall
Other clinical vocabularies don’t adequately
cover phenotypic descriptions
Winnenburg and Bodenreider, 2014
Percentcoverage
=> HPO is now in the UMLS
0
20
40
60
80
100
HPO
UMLS
SNOMEDCT
CHV
MedDRA
MeSH
NCIT
ICD10
OMIM
Precision fuzzy phenotype matching
DOI: 10.1126/scitranslmed.3009262
How much phenotyping is enough?
Enlarged ears (2)Dark hair (6) Female (4)
Male (4)
Blue skin (1)
Pointy ears (1)
Hair absent on head (1)
Horns present (1)
Hair present
on head (7)
Enlarged lip (2)
Increased skin
pigmentation (3)
bit.ly/annotationsufficiency
Matchmaker Exchange for patients, diseases, and model
organisms
Computational matching of rare disease patients across clinical & public sources
Find models and experts for functional validation
bit.ly/mme-matchbox
patientarchive.org
bit.ly/exomiser-2017
Plain language synonyms for computable
phenotypes
Layperson-HPO driven phenotyping tool
https://www.pcori.org/research-results/2017/realization-standard-care-rare-
diseases-using-patient-engaged-phenotyping
Catherine Brownstein, Ingrid Holm
NCI Thesaurus is the de facto cancer
vocabulary standard
Required for drug trials by FDA, but not interoperable with other vocabulary standards
Sequence
Ontology
Uberon
Anatomy
Ontology
Genotype
Ontology
MONDO
Disease
Ontology
Human
Phenotype
Ontology NCBIGene
Reactome
NCBITaxon
Protein
Ontology
ChEBI chemical
entities ontology
UNII chemical
substance registry
Cell
Ontology
Cell
Ontology
Ontology of
Biomedical
Investigations
Gene
Ontology
(GO-BP)
Uberon
Anatomy
Ontology
Gene
Ontology
(GO-CC)
UniProt
Tailoring the NCIt for computational
interoperability
https://github.com/NCI-Thesaurus
ICD-O and Oncotree slims available too:
https://github.com/NCI-Thesaurus/thesaurus-obo-edition/wiki/Downloads
Sequence
Ontology
Uberon
Anatomy
Ontology
Genotype
Ontology
MONDO
Disease
Ontology
Human
Phenotype
Ontology NCBIGene
Reactome
NCBITaxon
Protein
Ontology
ChEBI chemical
entities ontology
UNII chemical
substance registry
Cell
Ontology
Cell
Ontology
Ontology of
Biomedical
Investigations
Gene
Ontology
(GO-BP)
Uberon
Anatomy
Ontology
Gene
Ontology
(GO-CC)
UniProt
Lobular Breast Carcinoma =
'Breast Adenocarcinoma'
and (Disease_Has_Normal_Tissue_Origin some 'Terminal Ductal Lobular Unit')
and (Disease_Has_Normal_Cell_Origin some 'Terminal Ductal Lobular Unit Cell')
and (Disease_Has_Abnormal_Cell some 'Lobular Carcinoma Cell')
and (Disease_May_Have_Cytogenetic_Abnormality some 'Loss of Chromosome 16q')
and (Disease_Excludes_Abnormal_Cell some 'Ductal Carcinoma Cell')
and (Disease_Excludes_Finding some 'Mixed Cellular Population')
and (Disease_Mapped_To_Gene some 'CDH1 Gene')
and (Disease_May_Have_Molecular_Abnormality some 'Loss of E-cadherin Expression')
and (Disease_May_Have_Molecular_Abnormality some 'CDH1 Gene Inactivation')
Tailoring the NCIt for computational
interoperability
Jim Balhoff, Sherri DeCorronado, Giberto Fragoso, Nicole Vasilevsky,
Paula Carrio Caro, Matt Brush, Chris Mungall
Variant Pathogenicity Interpretations
Pathogenic ?
Benign ?
"DSC2:c.631-2A>G
Right
Ventricular
Cardiomyopathy
Complications to variant interpretation:
 Pathogenicity evidence is complex, diverse, indirect, conflicting
 Siloed curation guidelines
 High stakes (Applied directly to care)
Improving Rigor and Consistency of
Variant Interpretation
2015 ACMG-AMP Variant Interpretation Guidelines
 28 ‘criteria’ re: evidence types, strength
 Framework for combining criteria outcomes
ClinGen Variant Curation Interface (VCI) and DMWG
 Data model and curation for variant evidence and provenance
SEPIO Scientific Evidence and Provenance Information Ontology
 Computable model for representation and analysis of evidence and provenance
Merged Disease Classification
• Harmonized disease classification for algorithmic use and pathogenicity assignment
SEPIOScientific Evidence and
Provenance Information
Matt Brush, Selina Dwight, Larry Babb, Chris Bizon, Bradford Powell, Tristan Nelson, Bob Freimuth, Chris Mungall
co-localization evidence
functional
complementation evidence
microscopy evidence
imaging evidence
co-immunoprecipitation
evidence
:e4
Algorithms can leverage semantics of SEPIO models to compute
quantitative metrics of evidence quality, quantity, diversity, and
concordance – supporting automated evaluation of claims.
:e5:e3:e1 :e2
:claim1
“pathogenic”
:claim2
“benign”
Evidence-Based Computational
Evaluation of Claims
https://github.com/monarch-initiative/SEPIO-ontology/wiki
Disease 1 Disease 2
Data Standards Ontologies Data Standards Ontologies Data Standards Ontologies
Genes Environment Phenotypes
How do all these ontologies fit into our
notion of disease?
FHIR
Disease 1 Disease 2
Data Standards Ontologies Data Standards Ontologies Data Standards Ontologies
Genes Environment Phenotypes
FHIR
METADATA, EVIDENCE
Defining disease and clinical pathogenicity:
A lumping and splitting problem
source IDs
split/merge
manage
resolution &
provenance
MONDO Unified
Disease OntologySEPIOScientific Evidence and
Provenance Information
One disease or two?
What does the evidence favor?
One disease or two?
How do we manage identifiers, hierarchy?
OMIM
(brown)
MESH
(grey)
ORDO/Orphanet
(yellow)
SubClassOf
(solid line)
Xref
(dashed grey line)
Hemolytic anemia
mappings across
resources
Each nosology is different, they inconsistently map to each
other, leading to poor interoperability and computability
New integrated nosology
http://bit.ly/Monarch-Disease
http://purl.obolibrary.org/obo/mondo/pre/mondo.owl
Genes Environment Phenotypes
VCF PXFGFF
Standard exchange formats exist for genes …
but for phenotypes? Environment?
BED
http://phenopackets.org New Funding: Forums for Phenomics!
What does a phenopacket look like?
 Alacrima
 Sleep Apnea
 Microcephaly
phenotype_profile:
- entity: ”patient16"
phenotype:
types:
- id: "HP:0000522"
label: ”Alacrima"
onset:
description: “at birth”
types:
- id: "HP:0003577"
label: "Congenital onset"
evidence:
- types:
- id: "ECO:0000033"
label: ”Traceable Author Statement"
source:
- id: ”PMID:"
 Clinical labs
 Public databases
 Journals
Layperson HPO + Phenopackets
 Dry eyes
 Stops breathing during sleep
 Small head
phenotype_profile:
- entity: “Grace”
phenotype:
types:
- id: "HP:0000522"
label: “Alacrima"
onset:
description: “at birth"
types:
- id: "HP:0003577"
label: "Congenital onset"
evidence:
- types:
- id: “ECO:0000033”
label: “Traceable Author Statement"
source:
- id: “
https://twitter.com/examplepatient/status/1
23456789”
• Patient registries
• Social media
What’s next? Challenges for this
workstream
Figure out how ontologies, metadata, eHealth and exchange
standards all fit together in this workstream
Further harmonize existing disease and phenotype ontologies and
standards
Define exchange of structured phenotype data in different contexts:
clinical, basic research, patients, databases, journals
Getting structured G2P data–that is about the biology of the patient -
into/out of the EHR
Demonstrate standardization success across the driver projects
Discuss!

Más contenido relacionado

La actualidad más candente

Global Phenotypic Data Sharing Standards to Maximize Diagnostics and Mechanis...
Global Phenotypic Data Sharing Standards to Maximize Diagnostics and Mechanis...Global Phenotypic Data Sharing Standards to Maximize Diagnostics and Mechanis...
Global Phenotypic Data Sharing Standards to Maximize Diagnostics and Mechanis...mhaendel
 
The Monarch Initiative: From Model Organism to Precision Medicine
The Monarch Initiative: From Model Organism to Precision MedicineThe Monarch Initiative: From Model Organism to Precision Medicine
The Monarch Initiative: From Model Organism to Precision Medicinemhaendel
 
Why the world needs phenopacketeers, and how to be one
Why the world needs phenopacketeers, and how to be oneWhy the world needs phenopacketeers, and how to be one
Why the world needs phenopacketeers, and how to be onemhaendel
 
Phenopackets as applied to variant interpretation
Phenopackets as applied to variant interpretation Phenopackets as applied to variant interpretation
Phenopackets as applied to variant interpretation mhaendel
 
Semantic phenotyping for disease diagnosis and discovery
Semantic phenotyping for disease diagnosis and discovery Semantic phenotyping for disease diagnosis and discovery
Semantic phenotyping for disease diagnosis and discovery mhaendel
 
The Monarch Initiative: A semantic phenomics approach to disease discovery
The Monarch Initiative: A semantic phenomics approach to disease discoveryThe Monarch Initiative: A semantic phenomics approach to disease discovery
The Monarch Initiative: A semantic phenomics approach to disease discoverymhaendel
 
Use of semantic phenotyping to aid disease diagnosis
Use of semantic phenotyping to aid disease diagnosisUse of semantic phenotyping to aid disease diagnosis
Use of semantic phenotyping to aid disease diagnosismhaendel
 
Integrating clinical and model organism G2P data for disease discovery
Integrating clinical and model organism G2P data for disease discoveryIntegrating clinical and model organism G2P data for disease discovery
Integrating clinical and model organism G2P data for disease discoverymhaendel
 
On the frontier of genotype-2-phenotype data integration
On the frontier of genotype-2-phenotype data integrationOn the frontier of genotype-2-phenotype data integration
On the frontier of genotype-2-phenotype data integrationmhaendel
 
The Monarch Initiative: An integrated genotype-phenotype platform for disease...
The Monarch Initiative: An integrated genotype-phenotype platform for disease...The Monarch Initiative: An integrated genotype-phenotype platform for disease...
The Monarch Initiative: An integrated genotype-phenotype platform for disease...mhaendel
 
Envisioning a world where everyone helps solve disease
Envisioning a world where everyone helps solve diseaseEnvisioning a world where everyone helps solve disease
Envisioning a world where everyone helps solve diseasemhaendel
 
Enhancing the Human Phenotype Ontology for Use by the Layperson
Enhancing the Human Phenotype Ontology for Use by the LaypersonEnhancing the Human Phenotype Ontology for Use by the Layperson
Enhancing the Human Phenotype Ontology for Use by the LaypersonNicole Vasilevsky
 
Cell authentication by str profile
Cell authentication by str profileCell authentication by str profile
Cell authentication by str profileBennie George
 
Identify Disease-Associated Genetic Variants Via 3D Genomics Structure and Re...
Identify Disease-Associated Genetic Variants Via 3D Genomics Structure and Re...Identify Disease-Associated Genetic Variants Via 3D Genomics Structure and Re...
Identify Disease-Associated Genetic Variants Via 3D Genomics Structure and Re...Databricks
 
Monarch Initiative Poster - Rare Disease Symposium 2015
Monarch Initiative Poster - Rare Disease Symposium 2015Monarch Initiative Poster - Rare Disease Symposium 2015
Monarch Initiative Poster - Rare Disease Symposium 2015Nicole Vasilevsky
 
Hum. reprod. 2013-enciso-1707-15
Hum. reprod. 2013-enciso-1707-15Hum. reprod. 2013-enciso-1707-15
Hum. reprod. 2013-enciso-1707-15t7260678
 
What's In a Genotype?: An Ontological Characterization for the Integration of...
What's In a Genotype?: An Ontological Characterization for the Integration of...What's In a Genotype?: An Ontological Characterization for the Integration of...
What's In a Genotype?: An Ontological Characterization for the Integration of...mhb120
 
The Genomics Revolution: The Good, The Bad, and The Ugly (UEOP16 Keynote)
The Genomics Revolution: The Good, The Bad, and The Ugly (UEOP16 Keynote)The Genomics Revolution: The Good, The Bad, and The Ugly (UEOP16 Keynote)
The Genomics Revolution: The Good, The Bad, and The Ugly (UEOP16 Keynote)Emiliano De Cristofaro
 
Studying the elusive in larger scale
Studying the elusive in larger scaleStudying the elusive in larger scale
Studying the elusive in larger scaleChirag Patel
 

La actualidad más candente (20)

Global Phenotypic Data Sharing Standards to Maximize Diagnostics and Mechanis...
Global Phenotypic Data Sharing Standards to Maximize Diagnostics and Mechanis...Global Phenotypic Data Sharing Standards to Maximize Diagnostics and Mechanis...
Global Phenotypic Data Sharing Standards to Maximize Diagnostics and Mechanis...
 
The Monarch Initiative: From Model Organism to Precision Medicine
The Monarch Initiative: From Model Organism to Precision MedicineThe Monarch Initiative: From Model Organism to Precision Medicine
The Monarch Initiative: From Model Organism to Precision Medicine
 
Why the world needs phenopacketeers, and how to be one
Why the world needs phenopacketeers, and how to be oneWhy the world needs phenopacketeers, and how to be one
Why the world needs phenopacketeers, and how to be one
 
Phenopackets as applied to variant interpretation
Phenopackets as applied to variant interpretation Phenopackets as applied to variant interpretation
Phenopackets as applied to variant interpretation
 
Semantic phenotyping for disease diagnosis and discovery
Semantic phenotyping for disease diagnosis and discovery Semantic phenotyping for disease diagnosis and discovery
Semantic phenotyping for disease diagnosis and discovery
 
The Monarch Initiative: A semantic phenomics approach to disease discovery
The Monarch Initiative: A semantic phenomics approach to disease discoveryThe Monarch Initiative: A semantic phenomics approach to disease discovery
The Monarch Initiative: A semantic phenomics approach to disease discovery
 
Use of semantic phenotyping to aid disease diagnosis
Use of semantic phenotyping to aid disease diagnosisUse of semantic phenotyping to aid disease diagnosis
Use of semantic phenotyping to aid disease diagnosis
 
Integrating clinical and model organism G2P data for disease discovery
Integrating clinical and model organism G2P data for disease discoveryIntegrating clinical and model organism G2P data for disease discovery
Integrating clinical and model organism G2P data for disease discovery
 
On the frontier of genotype-2-phenotype data integration
On the frontier of genotype-2-phenotype data integrationOn the frontier of genotype-2-phenotype data integration
On the frontier of genotype-2-phenotype data integration
 
The Monarch Initiative: An integrated genotype-phenotype platform for disease...
The Monarch Initiative: An integrated genotype-phenotype platform for disease...The Monarch Initiative: An integrated genotype-phenotype platform for disease...
The Monarch Initiative: An integrated genotype-phenotype platform for disease...
 
Envisioning a world where everyone helps solve disease
Envisioning a world where everyone helps solve diseaseEnvisioning a world where everyone helps solve disease
Envisioning a world where everyone helps solve disease
 
Enhancing the Human Phenotype Ontology for Use by the Layperson
Enhancing the Human Phenotype Ontology for Use by the LaypersonEnhancing the Human Phenotype Ontology for Use by the Layperson
Enhancing the Human Phenotype Ontology for Use by the Layperson
 
Cell authentication by str profile
Cell authentication by str profileCell authentication by str profile
Cell authentication by str profile
 
Identify Disease-Associated Genetic Variants Via 3D Genomics Structure and Re...
Identify Disease-Associated Genetic Variants Via 3D Genomics Structure and Re...Identify Disease-Associated Genetic Variants Via 3D Genomics Structure and Re...
Identify Disease-Associated Genetic Variants Via 3D Genomics Structure and Re...
 
Monarch Initiative Poster - Rare Disease Symposium 2015
Monarch Initiative Poster - Rare Disease Symposium 2015Monarch Initiative Poster - Rare Disease Symposium 2015
Monarch Initiative Poster - Rare Disease Symposium 2015
 
Plegable final
Plegable finalPlegable final
Plegable final
 
Hum. reprod. 2013-enciso-1707-15
Hum. reprod. 2013-enciso-1707-15Hum. reprod. 2013-enciso-1707-15
Hum. reprod. 2013-enciso-1707-15
 
What's In a Genotype?: An Ontological Characterization for the Integration of...
What's In a Genotype?: An Ontological Characterization for the Integration of...What's In a Genotype?: An Ontological Characterization for the Integration of...
What's In a Genotype?: An Ontological Characterization for the Integration of...
 
The Genomics Revolution: The Good, The Bad, and The Ugly (UEOP16 Keynote)
The Genomics Revolution: The Good, The Bad, and The Ugly (UEOP16 Keynote)The Genomics Revolution: The Good, The Bad, and The Ugly (UEOP16 Keynote)
The Genomics Revolution: The Good, The Bad, and The Ugly (UEOP16 Keynote)
 
Studying the elusive in larger scale
Studying the elusive in larger scaleStudying the elusive in larger scale
Studying the elusive in larger scale
 

Similar a GA4GH Phenotype Ontologies Task team update

Haendel clingenetics.3.14.14
Haendel clingenetics.3.14.14Haendel clingenetics.3.14.14
Haendel clingenetics.3.14.14mhaendel
 
헬스케어 빅데이터로 무엇을 할 수 있는가?
헬스케어 빅데이터로 무엇을 할 수 있는가?헬스케어 빅데이터로 무엇을 할 수 있는가?
헬스케어 빅데이터로 무엇을 할 수 있는가? Hyung Jin Choi
 
Computing on Phenotypes AMP 2015
Computing on Phenotypes AMP 2015Computing on Phenotypes AMP 2015
Computing on Phenotypes AMP 2015Chris Mungall
 
Exploring your personal genome with free, online bioinformatics tools
Exploring your personal genome with free, online bioinformatics toolsExploring your personal genome with free, online bioinformatics tools
Exploring your personal genome with free, online bioinformatics tools01archivist
 
Repurposing large datasets for exposomic discovery in disease
Repurposing large datasets for exposomic discovery in diseaseRepurposing large datasets for exposomic discovery in disease
Repurposing large datasets for exposomic discovery in diseaseChirag Patel
 
GIGA2 Structuring Phenotype Data
GIGA2 Structuring Phenotype DataGIGA2 Structuring Phenotype Data
GIGA2 Structuring Phenotype DataChris Mungall
 
A New Generation Of Mechanism-Based Biomarkers For The Clinic
A New Generation Of Mechanism-Based Biomarkers For The ClinicA New Generation Of Mechanism-Based Biomarkers For The Clinic
A New Generation Of Mechanism-Based Biomarkers For The ClinicJoaquin Dopazo
 
My ontology is better than yours! Building and evaluating ontologies for inte...
My ontology is better than yours! Building and evaluating ontologies for inte...My ontology is better than yours! Building and evaluating ontologies for inte...
My ontology is better than yours! Building and evaluating ontologies for inte...Robert Hoehndorf
 
Gen epio immem_griffiths
Gen epio immem_griffithsGen epio immem_griffiths
Gen epio immem_griffithsIRIDA_community
 
IRIDA's Genomic epidemiology application ontology (GenEpiO): Genomic, clinica...
IRIDA's Genomic epidemiology application ontology (GenEpiO): Genomic, clinica...IRIDA's Genomic epidemiology application ontology (GenEpiO): Genomic, clinica...
IRIDA's Genomic epidemiology application ontology (GenEpiO): Genomic, clinica...Emma Griffiths
 
AACR 041616 digital exposomes
AACR 041616 digital exposomesAACR 041616 digital exposomes
AACR 041616 digital exposomesChirag Patel
 
Introducción a la bioinformatica
Introducción a la bioinformaticaIntroducción a la bioinformatica
Introducción a la bioinformaticaMartín Arrieta
 
Context is Everything: Integrating Genomics, Epidemiological and Clinical Dat...
Context is Everything: Integrating Genomics, Epidemiological and Clinical Dat...Context is Everything: Integrating Genomics, Epidemiological and Clinical Dat...
Context is Everything: Integrating Genomics, Epidemiological and Clinical Dat...Emma Griffiths
 
The IGM N-of-One Diagnostic Interpretation for Genetic Disorders
The IGM N-of-One Diagnostic Interpretation for Genetic DisordersThe IGM N-of-One Diagnostic Interpretation for Genetic Disorders
The IGM N-of-One Diagnostic Interpretation for Genetic Disorderssp3347
 
A Retrospective Analysis of Exome Sequencing Cases Using the GenePool™ Genomi...
A Retrospective Analysis of Exome Sequencing Cases Using the GenePool™ Genomi...A Retrospective Analysis of Exome Sequencing Cases Using the GenePool™ Genomi...
A Retrospective Analysis of Exome Sequencing Cases Using the GenePool™ Genomi...Antoaneta Vladimirova
 
Basic Formal Ontology (BFO) and Disease
 Basic Formal Ontology (BFO) and Disease Basic Formal Ontology (BFO) and Disease
Basic Formal Ontology (BFO) and DiseaseBarry Smith
 
Human Disease Ontology Project presented at ISB's Biocurator meeting April 2014
Human Disease Ontology Project presented at ISB's Biocurator meeting April 2014Human Disease Ontology Project presented at ISB's Biocurator meeting April 2014
Human Disease Ontology Project presented at ISB's Biocurator meeting April 2014Lynn Schriml
 
(서울의대 공유용) 빅데이터 분석 유전체 정보와 개인라이프로그 정보 활용-2015_11_24
(서울의대 공유용) 빅데이터 분석  유전체 정보와 개인라이프로그 정보 활용-2015_11_24(서울의대 공유용) 빅데이터 분석  유전체 정보와 개인라이프로그 정보 활용-2015_11_24
(서울의대 공유용) 빅데이터 분석 유전체 정보와 개인라이프로그 정보 활용-2015_11_24Hyung Jin Choi
 

Similar a GA4GH Phenotype Ontologies Task team update (20)

Haendel clingenetics.3.14.14
Haendel clingenetics.3.14.14Haendel clingenetics.3.14.14
Haendel clingenetics.3.14.14
 
헬스케어 빅데이터로 무엇을 할 수 있는가?
헬스케어 빅데이터로 무엇을 할 수 있는가?헬스케어 빅데이터로 무엇을 할 수 있는가?
헬스케어 빅데이터로 무엇을 할 수 있는가?
 
Computing on Phenotypes AMP 2015
Computing on Phenotypes AMP 2015Computing on Phenotypes AMP 2015
Computing on Phenotypes AMP 2015
 
Exploring your personal genome with free, online bioinformatics tools
Exploring your personal genome with free, online bioinformatics toolsExploring your personal genome with free, online bioinformatics tools
Exploring your personal genome with free, online bioinformatics tools
 
Repurposing large datasets for exposomic discovery in disease
Repurposing large datasets for exposomic discovery in diseaseRepurposing large datasets for exposomic discovery in disease
Repurposing large datasets for exposomic discovery in disease
 
GIGA2 Structuring Phenotype Data
GIGA2 Structuring Phenotype DataGIGA2 Structuring Phenotype Data
GIGA2 Structuring Phenotype Data
 
A New Generation Of Mechanism-Based Biomarkers For The Clinic
A New Generation Of Mechanism-Based Biomarkers For The ClinicA New Generation Of Mechanism-Based Biomarkers For The Clinic
A New Generation Of Mechanism-Based Biomarkers For The Clinic
 
My ontology is better than yours! Building and evaluating ontologies for inte...
My ontology is better than yours! Building and evaluating ontologies for inte...My ontology is better than yours! Building and evaluating ontologies for inte...
My ontology is better than yours! Building and evaluating ontologies for inte...
 
Gen epio immem_griffiths
Gen epio immem_griffithsGen epio immem_griffiths
Gen epio immem_griffiths
 
IRIDA's Genomic epidemiology application ontology (GenEpiO): Genomic, clinica...
IRIDA's Genomic epidemiology application ontology (GenEpiO): Genomic, clinica...IRIDA's Genomic epidemiology application ontology (GenEpiO): Genomic, clinica...
IRIDA's Genomic epidemiology application ontology (GenEpiO): Genomic, clinica...
 
AACR 041616 digital exposomes
AACR 041616 digital exposomesAACR 041616 digital exposomes
AACR 041616 digital exposomes
 
Introducción a la bioinformatica
Introducción a la bioinformaticaIntroducción a la bioinformatica
Introducción a la bioinformatica
 
Context is Everything: Integrating Genomics, Epidemiological and Clinical Dat...
Context is Everything: Integrating Genomics, Epidemiological and Clinical Dat...Context is Everything: Integrating Genomics, Epidemiological and Clinical Dat...
Context is Everything: Integrating Genomics, Epidemiological and Clinical Dat...
 
The IGM N-of-One Diagnostic Interpretation for Genetic Disorders
The IGM N-of-One Diagnostic Interpretation for Genetic DisordersThe IGM N-of-One Diagnostic Interpretation for Genetic Disorders
The IGM N-of-One Diagnostic Interpretation for Genetic Disorders
 
A Retrospective Analysis of Exome Sequencing Cases Using the GenePool™ Genomi...
A Retrospective Analysis of Exome Sequencing Cases Using the GenePool™ Genomi...A Retrospective Analysis of Exome Sequencing Cases Using the GenePool™ Genomi...
A Retrospective Analysis of Exome Sequencing Cases Using the GenePool™ Genomi...
 
Basic Formal Ontology (BFO) and Disease
 Basic Formal Ontology (BFO) and Disease Basic Formal Ontology (BFO) and Disease
Basic Formal Ontology (BFO) and Disease
 
Bioinformatics
BioinformaticsBioinformatics
Bioinformatics
 
Duzkale_2013_Variant Interpretation_
Duzkale_2013_Variant Interpretation_Duzkale_2013_Variant Interpretation_
Duzkale_2013_Variant Interpretation_
 
Human Disease Ontology Project presented at ISB's Biocurator meeting April 2014
Human Disease Ontology Project presented at ISB's Biocurator meeting April 2014Human Disease Ontology Project presented at ISB's Biocurator meeting April 2014
Human Disease Ontology Project presented at ISB's Biocurator meeting April 2014
 
(서울의대 공유용) 빅데이터 분석 유전체 정보와 개인라이프로그 정보 활용-2015_11_24
(서울의대 공유용) 빅데이터 분석  유전체 정보와 개인라이프로그 정보 활용-2015_11_24(서울의대 공유용) 빅데이터 분석  유전체 정보와 개인라이프로그 정보 활용-2015_11_24
(서울의대 공유용) 빅데이터 분석 유전체 정보와 개인라이프로그 정보 활용-2015_11_24
 

Más de mhaendel

The Software and Data Licensing Solution: Not Your Dad’s UBMTA
The Software and Data Licensing Solution: Not Your Dad’s UBMTA The Software and Data Licensing Solution: Not Your Dad’s UBMTA
The Software and Data Licensing Solution: Not Your Dad’s UBMTA mhaendel
 
Equivalence is in the (ID) of the beholder
Equivalence is in the (ID) of the beholderEquivalence is in the (ID) of the beholder
Equivalence is in the (ID) of the beholdermhaendel
 
Building (and traveling) the data-brick road: A report from the front lines ...
Building (and traveling) the data-brick road:  A report from the front lines ...Building (and traveling) the data-brick road:  A report from the front lines ...
Building (and traveling) the data-brick road: A report from the front lines ...mhaendel
 
Reusable data for biomedicine: A data licensing odyssey
Reusable data for biomedicine:  A data licensing odysseyReusable data for biomedicine:  A data licensing odyssey
Reusable data for biomedicine: A data licensing odysseymhaendel
 
How open is open? An evaluation rubric for public knowledgebases
How open is open?  An evaluation rubric for public knowledgebasesHow open is open?  An evaluation rubric for public knowledgebases
How open is open? An evaluation rubric for public knowledgebasesmhaendel
 
Science in the open, what does it take?
Science in the open, what does it take?Science in the open, what does it take?
Science in the open, what does it take?mhaendel
 
Credit where credit is due: acknowledging all types of contributions
Credit where credit is due: acknowledging all types of contributionsCredit where credit is due: acknowledging all types of contributions
Credit where credit is due: acknowledging all types of contributionsmhaendel
 
Getting (and giving) credit for all that we do
Getting (and giving) credit for all that we doGetting (and giving) credit for all that we do
Getting (and giving) credit for all that we domhaendel
 
Force11: Enabling transparency and efficiency in the research landscape
Force11: Enabling transparency and efficiency in the research landscapeForce11: Enabling transparency and efficiency in the research landscape
Force11: Enabling transparency and efficiency in the research landscapemhaendel
 
Dataset description using the W3C HCLS standard
Dataset description using the W3C HCLS standardDataset description using the W3C HCLS standard
Dataset description using the W3C HCLS standardmhaendel
 
On the nature of Credit
On the nature of CreditOn the nature of Credit
On the nature of Creditmhaendel
 
Standardizing scholarly output with the VIVO ontology
Standardizing scholarly output with the VIVO ontologyStandardizing scholarly output with the VIVO ontology
Standardizing scholarly output with the VIVO ontologymhaendel
 

Más de mhaendel (12)

The Software and Data Licensing Solution: Not Your Dad’s UBMTA
The Software and Data Licensing Solution: Not Your Dad’s UBMTA The Software and Data Licensing Solution: Not Your Dad’s UBMTA
The Software and Data Licensing Solution: Not Your Dad’s UBMTA
 
Equivalence is in the (ID) of the beholder
Equivalence is in the (ID) of the beholderEquivalence is in the (ID) of the beholder
Equivalence is in the (ID) of the beholder
 
Building (and traveling) the data-brick road: A report from the front lines ...
Building (and traveling) the data-brick road:  A report from the front lines ...Building (and traveling) the data-brick road:  A report from the front lines ...
Building (and traveling) the data-brick road: A report from the front lines ...
 
Reusable data for biomedicine: A data licensing odyssey
Reusable data for biomedicine:  A data licensing odysseyReusable data for biomedicine:  A data licensing odyssey
Reusable data for biomedicine: A data licensing odyssey
 
How open is open? An evaluation rubric for public knowledgebases
How open is open?  An evaluation rubric for public knowledgebasesHow open is open?  An evaluation rubric for public knowledgebases
How open is open? An evaluation rubric for public knowledgebases
 
Science in the open, what does it take?
Science in the open, what does it take?Science in the open, what does it take?
Science in the open, what does it take?
 
Credit where credit is due: acknowledging all types of contributions
Credit where credit is due: acknowledging all types of contributionsCredit where credit is due: acknowledging all types of contributions
Credit where credit is due: acknowledging all types of contributions
 
Getting (and giving) credit for all that we do
Getting (and giving) credit for all that we doGetting (and giving) credit for all that we do
Getting (and giving) credit for all that we do
 
Force11: Enabling transparency and efficiency in the research landscape
Force11: Enabling transparency and efficiency in the research landscapeForce11: Enabling transparency and efficiency in the research landscape
Force11: Enabling transparency and efficiency in the research landscape
 
Dataset description using the W3C HCLS standard
Dataset description using the W3C HCLS standardDataset description using the W3C HCLS standard
Dataset description using the W3C HCLS standard
 
On the nature of Credit
On the nature of CreditOn the nature of Credit
On the nature of Credit
 
Standardizing scholarly output with the VIVO ontology
Standardizing scholarly output with the VIVO ontologyStandardizing scholarly output with the VIVO ontology
Standardizing scholarly output with the VIVO ontology
 

Último

Hubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroidsHubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroidsSérgio Sacani
 
❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.
❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.
❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.Nitya salvi
 
Pests of mustard_Identification_Management_Dr.UPR.pdf
Pests of mustard_Identification_Management_Dr.UPR.pdfPests of mustard_Identification_Management_Dr.UPR.pdf
Pests of mustard_Identification_Management_Dr.UPR.pdfPirithiRaju
 
GBSN - Microbiology (Unit 2)
GBSN - Microbiology (Unit 2)GBSN - Microbiology (Unit 2)
GBSN - Microbiology (Unit 2)Areesha Ahmad
 
Spermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatidSpermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatidSarthak Sekhar Mondal
 
Green chemistry and Sustainable development.pptx
Green chemistry  and Sustainable development.pptxGreen chemistry  and Sustainable development.pptx
Green chemistry and Sustainable development.pptxRajatChauhan518211
 
Chemistry 4th semester series (krishna).pdf
Chemistry 4th semester series (krishna).pdfChemistry 4th semester series (krishna).pdf
Chemistry 4th semester series (krishna).pdfSumit Kumar yadav
 
Botany 4th semester file By Sumit Kumar yadav.pdf
Botany 4th semester file By Sumit Kumar yadav.pdfBotany 4th semester file By Sumit Kumar yadav.pdf
Botany 4th semester file By Sumit Kumar yadav.pdfSumit Kumar yadav
 
Pests of cotton_Borer_Pests_Binomics_Dr.UPR.pdf
Pests of cotton_Borer_Pests_Binomics_Dr.UPR.pdfPests of cotton_Borer_Pests_Binomics_Dr.UPR.pdf
Pests of cotton_Borer_Pests_Binomics_Dr.UPR.pdfPirithiRaju
 
Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptxUnlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptxanandsmhk
 
Isotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on IoIsotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on IoSérgio Sacani
 
Pests of cotton_Sucking_Pests_Dr.UPR.pdf
Pests of cotton_Sucking_Pests_Dr.UPR.pdfPests of cotton_Sucking_Pests_Dr.UPR.pdf
Pests of cotton_Sucking_Pests_Dr.UPR.pdfPirithiRaju
 
Formation of low mass protostars and their circumstellar disks
Formation of low mass protostars and their circumstellar disksFormation of low mass protostars and their circumstellar disks
Formation of low mass protostars and their circumstellar disksSérgio Sacani
 
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bNightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bSérgio Sacani
 
Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )aarthirajkumar25
 
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service 🪡
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service  🪡CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service  🪡
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service 🪡anilsa9823
 
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...Sérgio Sacani
 
GBSN - Biochemistry (Unit 1)
GBSN - Biochemistry (Unit 1)GBSN - Biochemistry (Unit 1)
GBSN - Biochemistry (Unit 1)Areesha Ahmad
 
DIFFERENCE IN BACK CROSS AND TEST CROSS
DIFFERENCE IN  BACK CROSS AND TEST CROSSDIFFERENCE IN  BACK CROSS AND TEST CROSS
DIFFERENCE IN BACK CROSS AND TEST CROSSLeenakshiTyagi
 
fundamental of entomology all in one topics of entomology
fundamental of entomology all in one topics of entomologyfundamental of entomology all in one topics of entomology
fundamental of entomology all in one topics of entomologyDrAnita Sharma
 

Último (20)

Hubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroidsHubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroids
 
❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.
❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.
❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.
 
Pests of mustard_Identification_Management_Dr.UPR.pdf
Pests of mustard_Identification_Management_Dr.UPR.pdfPests of mustard_Identification_Management_Dr.UPR.pdf
Pests of mustard_Identification_Management_Dr.UPR.pdf
 
GBSN - Microbiology (Unit 2)
GBSN - Microbiology (Unit 2)GBSN - Microbiology (Unit 2)
GBSN - Microbiology (Unit 2)
 
Spermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatidSpermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatid
 
Green chemistry and Sustainable development.pptx
Green chemistry  and Sustainable development.pptxGreen chemistry  and Sustainable development.pptx
Green chemistry and Sustainable development.pptx
 
Chemistry 4th semester series (krishna).pdf
Chemistry 4th semester series (krishna).pdfChemistry 4th semester series (krishna).pdf
Chemistry 4th semester series (krishna).pdf
 
Botany 4th semester file By Sumit Kumar yadav.pdf
Botany 4th semester file By Sumit Kumar yadav.pdfBotany 4th semester file By Sumit Kumar yadav.pdf
Botany 4th semester file By Sumit Kumar yadav.pdf
 
Pests of cotton_Borer_Pests_Binomics_Dr.UPR.pdf
Pests of cotton_Borer_Pests_Binomics_Dr.UPR.pdfPests of cotton_Borer_Pests_Binomics_Dr.UPR.pdf
Pests of cotton_Borer_Pests_Binomics_Dr.UPR.pdf
 
Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptxUnlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptx
 
Isotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on IoIsotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on Io
 
Pests of cotton_Sucking_Pests_Dr.UPR.pdf
Pests of cotton_Sucking_Pests_Dr.UPR.pdfPests of cotton_Sucking_Pests_Dr.UPR.pdf
Pests of cotton_Sucking_Pests_Dr.UPR.pdf
 
Formation of low mass protostars and their circumstellar disks
Formation of low mass protostars and their circumstellar disksFormation of low mass protostars and their circumstellar disks
Formation of low mass protostars and their circumstellar disks
 
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bNightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
 
Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )
 
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service 🪡
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service  🪡CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service  🪡
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service 🪡
 
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
 
GBSN - Biochemistry (Unit 1)
GBSN - Biochemistry (Unit 1)GBSN - Biochemistry (Unit 1)
GBSN - Biochemistry (Unit 1)
 
DIFFERENCE IN BACK CROSS AND TEST CROSS
DIFFERENCE IN  BACK CROSS AND TEST CROSSDIFFERENCE IN  BACK CROSS AND TEST CROSS
DIFFERENCE IN BACK CROSS AND TEST CROSS
 
fundamental of entomology all in one topics of entomology
fundamental of entomology all in one topics of entomologyfundamental of entomology all in one topics of entomology
fundamental of entomology all in one topics of entomology
 

GA4GH Phenotype Ontologies Task team update

  • 2. Genes Environment Phenotypes Determinants of Health are Diverse  Physical environment  Chemical exposures  Treatments  Smoking, alcohol  Education  Health services  Income  Social status  Stress  Employment  Working conditions  Microbiome  Pathogens  Clinical observations  Laboratory tests  Patient reported outcomes  Child development  Biometrics  Behaviors  Sleep  Exercise  Screen time  Diet  Genomic endowment  Epigenetics  Gene expression  Gene regulation Ontologies can help make (some of) this computable
  • 3. Genes Environment Phenotypes+ = But its not just the types of things
  • 4. …the relationships and their evidence must also be captured G-P or D (disease) • causes • contributes to • is risk factor for • protects against • correlates with • is marker for • modulates • involved in • increases susceptibility to G-G (kind of) • regulates • negatively regulates (inhibits) • positively regulates (activates) • directly regulates • interacts with • co-localizes with • co-expressed with P/D - P/D • part of • results in • co-occurs with • correlates with • hallmark of (P->D) E-P • contributes to (E->P) • influences (E->P) • exacerbates (E->P) • manifest in (P->E) G-E (kind of) • expressed in • expressed during • contains • inactivated by
  • 5. The Human Phenotype Ontology  11,813 phenotype terms  127,125 rare disease - phenotype annotations  136,268 common disease - phenotype annotations bit.ly/hpo-paper Peter Robinson, Sebastian Koehler, Chris Mungall
  • 6. Other clinical vocabularies don’t adequately cover phenotypic descriptions Winnenburg and Bodenreider, 2014 Percentcoverage => HPO is now in the UMLS 0 20 40 60 80 100 HPO UMLS SNOMEDCT CHV MedDRA MeSH NCIT ICD10 OMIM
  • 7. Precision fuzzy phenotype matching DOI: 10.1126/scitranslmed.3009262
  • 8. How much phenotyping is enough? Enlarged ears (2)Dark hair (6) Female (4) Male (4) Blue skin (1) Pointy ears (1) Hair absent on head (1) Horns present (1) Hair present on head (7) Enlarged lip (2) Increased skin pigmentation (3) bit.ly/annotationsufficiency
  • 9. Matchmaker Exchange for patients, diseases, and model organisms Computational matching of rare disease patients across clinical & public sources Find models and experts for functional validation bit.ly/mme-matchbox patientarchive.org bit.ly/exomiser-2017
  • 10. Plain language synonyms for computable phenotypes
  • 11. Layperson-HPO driven phenotyping tool https://www.pcori.org/research-results/2017/realization-standard-care-rare- diseases-using-patient-engaged-phenotyping Catherine Brownstein, Ingrid Holm
  • 12. NCI Thesaurus is the de facto cancer vocabulary standard Required for drug trials by FDA, but not interoperable with other vocabulary standards
  • 13. Sequence Ontology Uberon Anatomy Ontology Genotype Ontology MONDO Disease Ontology Human Phenotype Ontology NCBIGene Reactome NCBITaxon Protein Ontology ChEBI chemical entities ontology UNII chemical substance registry Cell Ontology Cell Ontology Ontology of Biomedical Investigations Gene Ontology (GO-BP) Uberon Anatomy Ontology Gene Ontology (GO-CC) UniProt Tailoring the NCIt for computational interoperability https://github.com/NCI-Thesaurus ICD-O and Oncotree slims available too: https://github.com/NCI-Thesaurus/thesaurus-obo-edition/wiki/Downloads
  • 14. Sequence Ontology Uberon Anatomy Ontology Genotype Ontology MONDO Disease Ontology Human Phenotype Ontology NCBIGene Reactome NCBITaxon Protein Ontology ChEBI chemical entities ontology UNII chemical substance registry Cell Ontology Cell Ontology Ontology of Biomedical Investigations Gene Ontology (GO-BP) Uberon Anatomy Ontology Gene Ontology (GO-CC) UniProt Lobular Breast Carcinoma = 'Breast Adenocarcinoma' and (Disease_Has_Normal_Tissue_Origin some 'Terminal Ductal Lobular Unit') and (Disease_Has_Normal_Cell_Origin some 'Terminal Ductal Lobular Unit Cell') and (Disease_Has_Abnormal_Cell some 'Lobular Carcinoma Cell') and (Disease_May_Have_Cytogenetic_Abnormality some 'Loss of Chromosome 16q') and (Disease_Excludes_Abnormal_Cell some 'Ductal Carcinoma Cell') and (Disease_Excludes_Finding some 'Mixed Cellular Population') and (Disease_Mapped_To_Gene some 'CDH1 Gene') and (Disease_May_Have_Molecular_Abnormality some 'Loss of E-cadherin Expression') and (Disease_May_Have_Molecular_Abnormality some 'CDH1 Gene Inactivation') Tailoring the NCIt for computational interoperability Jim Balhoff, Sherri DeCorronado, Giberto Fragoso, Nicole Vasilevsky, Paula Carrio Caro, Matt Brush, Chris Mungall
  • 15. Variant Pathogenicity Interpretations Pathogenic ? Benign ? "DSC2:c.631-2A>G Right Ventricular Cardiomyopathy Complications to variant interpretation:  Pathogenicity evidence is complex, diverse, indirect, conflicting  Siloed curation guidelines  High stakes (Applied directly to care)
  • 16. Improving Rigor and Consistency of Variant Interpretation 2015 ACMG-AMP Variant Interpretation Guidelines  28 ‘criteria’ re: evidence types, strength  Framework for combining criteria outcomes ClinGen Variant Curation Interface (VCI) and DMWG  Data model and curation for variant evidence and provenance SEPIO Scientific Evidence and Provenance Information Ontology  Computable model for representation and analysis of evidence and provenance Merged Disease Classification • Harmonized disease classification for algorithmic use and pathogenicity assignment SEPIOScientific Evidence and Provenance Information Matt Brush, Selina Dwight, Larry Babb, Chris Bizon, Bradford Powell, Tristan Nelson, Bob Freimuth, Chris Mungall
  • 17. co-localization evidence functional complementation evidence microscopy evidence imaging evidence co-immunoprecipitation evidence :e4 Algorithms can leverage semantics of SEPIO models to compute quantitative metrics of evidence quality, quantity, diversity, and concordance – supporting automated evaluation of claims. :e5:e3:e1 :e2 :claim1 “pathogenic” :claim2 “benign” Evidence-Based Computational Evaluation of Claims https://github.com/monarch-initiative/SEPIO-ontology/wiki
  • 18. Disease 1 Disease 2 Data Standards Ontologies Data Standards Ontologies Data Standards Ontologies Genes Environment Phenotypes How do all these ontologies fit into our notion of disease? FHIR
  • 19. Disease 1 Disease 2 Data Standards Ontologies Data Standards Ontologies Data Standards Ontologies Genes Environment Phenotypes FHIR METADATA, EVIDENCE
  • 20. Defining disease and clinical pathogenicity: A lumping and splitting problem source IDs split/merge manage resolution & provenance MONDO Unified Disease OntologySEPIOScientific Evidence and Provenance Information One disease or two? What does the evidence favor? One disease or two? How do we manage identifiers, hierarchy?
  • 21. OMIM (brown) MESH (grey) ORDO/Orphanet (yellow) SubClassOf (solid line) Xref (dashed grey line) Hemolytic anemia mappings across resources Each nosology is different, they inconsistently map to each other, leading to poor interoperability and computability
  • 23. Genes Environment Phenotypes VCF PXFGFF Standard exchange formats exist for genes … but for phenotypes? Environment? BED http://phenopackets.org New Funding: Forums for Phenomics!
  • 24. What does a phenopacket look like?  Alacrima  Sleep Apnea  Microcephaly phenotype_profile: - entity: ”patient16" phenotype: types: - id: "HP:0000522" label: ”Alacrima" onset: description: “at birth” types: - id: "HP:0003577" label: "Congenital onset" evidence: - types: - id: "ECO:0000033" label: ”Traceable Author Statement" source: - id: ”PMID:"  Clinical labs  Public databases  Journals
  • 25. Layperson HPO + Phenopackets  Dry eyes  Stops breathing during sleep  Small head phenotype_profile: - entity: “Grace” phenotype: types: - id: "HP:0000522" label: “Alacrima" onset: description: “at birth" types: - id: "HP:0003577" label: "Congenital onset" evidence: - types: - id: “ECO:0000033” label: “Traceable Author Statement" source: - id: “ https://twitter.com/examplepatient/status/1 23456789” • Patient registries • Social media
  • 26. What’s next? Challenges for this workstream Figure out how ontologies, metadata, eHealth and exchange standards all fit together in this workstream Further harmonize existing disease and phenotype ontologies and standards Define exchange of structured phenotype data in different contexts: clinical, basic research, patients, databases, journals Getting structured G2P data–that is about the biology of the patient - into/out of the EHR Demonstrate standardization success across the driver projects Discuss!

Notas del editor

  1. Image credit: http://www.enterrasolutions.com/ontology-power-understanding/
  2. The classic G+E=P. But the = has a lot that can be applied to aid the linking.
  3. The classic G+E=P. But the = has a lot that can be applied to aid the linking.
  4. The classic G+E=P. But the = has a lot that can be applied to aid the linking.
  5. not same variant, but same disease and same gene KMT2A http://stm.sciencemag.org/content/scitransmed/suppl/2014/08/29/6.252.252ra123.DC1/6-252ra123_SM.pdf (paywalled) DOI: 10.1126/scitranslmed.3009262
  6. Knowing what the normal distribution and clustering of phenotypes is helps us know that blue skin is rare and can reliably distinguish between phenotype profiles. Likewise to know that if the first phenotype entered is enlarged lip, the next one to ask for would be enlarged ears. The combination of 3 non-unique phenotypes offers a perfect match.
  7. FDA as well as PMDA (Japan) requires use of CDISC standards for all clinical trial submissions - human and animal toxicology. The SDTM standard (for human clinical trials) includes over 30,000 controlled terms coded in NCI Thesaurus.
  8. Axiom references anatomy/tissue, cell types, genes, findings/phenpotypes
  9. - variant pathogenicity classifications rely on nuanced interpretation of complex and diverse evidence. - this is a domain where capturing and computing on E/P metadata is essential for important applications in research and healthcare.
  10. 1. ACMG Guidelines: consistent interpretation and application of evidence set of 28 criteria defining relevant types of evidence and how to evaluate their strength a particular variant is evaluated against all criteria relevant to what is known about the variant - guidelines then provide a framework for combining outcomes of these 'criterion assessments' to derive a final classification into one of five categories - goal is more principled and consistent interpretation -> more reliable with fewer conflicts 2. ClinGen VCI: curation and exchange of evidence and provenance information collected in ACMG-gudied workflows CG developing VCI that implements the ACMG workflow – and capturing structured representations of rich/granular provenance and evidence metadata for each step in workflow   3. SEPIO: computable model for representing evidence and provenance information ClinGen is using SEPIO model to create extensible, integrated, computable data structures for data exchange and analysis ------------ ClinGen is using SEPIO ontology model to enable extensible, interoperable, and computable E/P metadata
  11. -- We can apply semantic similarity algorithms that use the graph-distance between classes, to estimate the similarity of the evidence lines these classes annotate. The idea here is that more diverse lines of evidence provide stronger support for a claim than closely related ones.
  12. https://github.com/monarch-initiative/monarch-disease-ontology/issues/90 Note the two subgraphs; little overlap in the upper areas
  13. The classic G+E=P. But the = has a lot that can be applied to aid the linking.